← All stocks

Mineralys Therapeutics, Inc.

MLYS Net buying

CIK 0001933414 #1952 in the set updated 17 Sep 2026

Bought (120 mo)

$142.67M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$102.60M

$13.11M on a plan · $28.79M straight out of an exercise

Sold at will

$60.69M

12 of 122 sales

Net

+$40.07M

+$81.97M against sales at will

By person

14 insiders · 173 transactions

24.6×

Jon Congleton holds 24.6 times base salary in stock. $15.68M of shares against $636.50K in salary for 2025.

Salary from the company's own proxy. The shares are what Jon Congleton last reported holding, valued at $25.98, the price Common Stock was last bought or sold at on the open market here, on 21 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

RA CAPITAL MANAGEMENT, L.P. entity

Director

$76.26M (6)

—

+$76.26M

5,825,521

6.59%

$151.33M

—

Slingsby Brian Taylor

Director

$7.50M (2)

$50.53M (2)

−$43.03M

7,910,038

8.95%

$205.48M

+70.8%

AKKARAJU SRINIVAS

Director

$38.10M (3)

—

+$38.10M

594,435

0.6724%

$15.44M

—

Rodman David Malcom

Chief Medical Officer

—

$19.98M (57) scheduled

−$19.98M

51,384

0.0581%

$1.33M

+674.8%

Congleton Jon

Chief Executive Officer

$105.54K (4)

$17.42M (28)

−$17.32M

603,621

0.6828%

$15.68M

−41.9%

Samsara BioCapital GP, LLC entity

10% owner

$15.60M (2)

—

+$15.60M

5,674,916

6.42%

$147.42M

+25.6%

Levy Adam Scott

CFO and Secretary

$100.00K (1)

$9.16M (23) scheduled

−$9.06M

48,538

0.0549%

$1.26M

−81.5%

HBM Healthcare Investments (Cayman) Ltd. entity

10% owner

$5.00M (1)

—

+$5.00M

3,218,106

3.64%

$83.60M

—

Warren Eric

Chief Commercial Officer

—

$3.09M (3) scheduled

−$3.09M

38,400

0.0434%

$997.51K

0.0%

Gold Alexander M

Director

—

$1.58M (5) scheduled

−$1.58M

6,200

0.0070%

$161.06K

—

Karydas Daphne

Director

—

$839.80K (4) scheduled

−$839.80K

6,200

0.0070%

$161.06K

—

Ferguson James J. III

Chief Medical Officer

—

102,400

0.1158%

$2.66M

—

SBLENDORIO GLENN

Director

—

6,200

0.0070%

$161.06K

—

DiRocco Derek

Director

—

6,200

0.0070%

$161.06K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

RA CAPITAL MANAGEMENT, L.P.

30 Mar 2026

Director

Buy indirect

58,300

$24.16

$1.41M

RA CAPITAL MANAGEMENT, L.P.

27 Mar 2026

Director

Buy indirect

310,700

$23.67

$7.35M

RA CAPITAL MANAGEMENT, L.P.

4 Sep 2025

Director

Buy indirect

1,176,470

$25.50

$30.00M

AKKARAJU SRINIVAS

4 Sep 2025

Director

Buy indirect

588,235

$25.50

$15.00M

RA CAPITAL MANAGEMENT, L.P.

13 Mar 2025

Director

Buy indirect

1,296,296

$13.50

$17.50M

AKKARAJU SRINIVAS

13 Mar 2025

Director

Buy indirect

600,000

$13.50

$8.10M

Samsara BioCapital GP, LLC

13 Mar 2025

10% owner

Buy indirect

600,000

$13.50

$8.10M

Slingsby Brian Taylor

13 Mar 2025

Director

Buy indirect

259,259

$13.50

$3.50M

Samsara BioCapital GP, LLC

12 Feb 2024

10% owner

Buy indirect

555,555

$13.50

$7.50M

Congleton Jon

22 Nov 2023

Chief Executive Officer

Buy

4,250

$5.97

$25.36K

Congleton Jon

6 Sep 2023

Chief Executive Officer

Buy

2,250

$12.08

$27.18K

Congleton Jon

17 Aug 2023

Chief Executive Officer

Buy

2,250

$12.10

$27.23K

Congleton Jon

11 Aug 2023

Chief Executive Officer

Buy

2,000

$12.89

$25.78K

Slingsby Brian Taylor

14 Feb 2023

Director

Buy indirect

250,000

$16.00

$4.00M

AKKARAJU SRINIVAS

14 Feb 2023

Director

Buy indirect

937,500

$16.00

$15.00M

Levy Adam Scott

14 Feb 2023

CFO, Chief Bus. Off. and Secy.

Buy

6,250

$16.00

$100.00K

RA CAPITAL MANAGEMENT, L.P.

14 Feb 2023

Director

Buy indirect

1,118,400

$16.00

$17.89M

RA CAPITAL MANAGEMENT, L.P.

14 Feb 2023

Director

Buy indirect

131,600

$16.00

$2.11M

HBM Healthcare Investments (Cayman) Ltd.

14 Feb 2023

10% owner

Buy

312,500

$16.00

$5.00M

Show all 173 transactions →

Mineralys Therapeutics, Inc.

By person

Individual transactions

What was left out